Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancratic Ductal Adenocarcinoma”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableStudy completedNCT04348084
What this trial is testing

Oncologic Impact of Pancreatic Fistula

Who this might be right for
PDAC of the Body and the Tail of the PancreasCR- POPF
University Hospital, Montpellier 382
Testing effectiveness (Phase 2)Active Not RecruitingNCT07806110
What this trial is testing

Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreas Ductal Adenocarcinoma
The First Hospital of Jilin University 62
Very early researchLooking for participantsNCT06828328
What this trial is testing

GC203 TIL in PDCA (RJ)

Who this might be right for
Pancreatic CancerPancratic Ductal AdenocarcinomaTreatment Side Effects+1 more
Shanghai Juncell Therapeutics 10